How may patients with MS benefit from using music assisted therapy? A case-control feasability study investigating motor outcomes and beyond.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 14 11 2020
revised: 10 12 2020
accepted: 19 12 2020
pubmed: 3 1 2021
medline: 15 5 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

Motor impairment is the most common symptom in multiple sclerosis (MS), as gait and balance dysfunction are reported in more than 85% of the patients, with considerable consequences on the patient's activities of daily living and psychological status. This study aimed at evaluating the feasibility and potential efficacy of a novel treatment involving music plus treadmill in patients with MS. Ten patients affected by secondary progressive MS were submitted to a specific training using the Gait Trainer (GT) 3, a platform that integrates gait training via a treadmill and rhythmic auditory stimulation. The 30 minutes training was performed three times per week for eight weeks (24 sessions in total). The enrolled patients were compared with a control group (CG) of 10 patients with MS matched for age, gender, disease duration, and EDSS stage. The CG received the same amount of treatment, but using conventional overground gait training. All patients completed the training without reporting any side effects. At the end of the training, CG improved in static and dynamic balance and in mood. Instead, in the EG a significant improvement in static and dynamic balance, walking speed, and mobility, as well as in mood, and perception of quality of life (QoL), both for physical and mental well-being, was found. This exploratory study suggests that GT3 might be a feasible and potentially useful approach for MS gait rehabilitation, thanks to patients' high motivation and good acceptance of the music assisted therapy.

Identifiants

pubmed: 33387863
pii: S2211-0348(20)30787-2
doi: 10.1016/j.msard.2020.102713
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102713

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Maria Grazia Maggio (MG)

Studio di Psicoterapia Relazionale e Riabilitazione Cognitiva, viale Europa, 107, Messina, Italy.

Daniele Tripoli (D)

Azienda Ospedaliera Papardo, Messina, Italy.

Bruno Porcari (B)

IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy.

Alfredo Manuli (A)

Azienda Sanitaria Provinciale di Ragusa, Ragusa, Italy.

Serena Filoni (S)

Padre Pio Foundation and Rehabilitation Centers, San Giovanni Rotondo, Foggia, Italy.

Antonino Naro (A)

IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy.

Mareike Eschweiler (M)

Neurological Rehabilitation Center "Godeshoehe" e.V., Bonn, Germany.

Rocco Salvatore Calabrò (RS)

IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy. Electronic address: salbro77@tiscali.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH